Table 1.
Missense Mutations | ||||||||
---|---|---|---|---|---|---|---|---|
No. | Author | Exon | Allele | n | Protein | Binding | IP3 Signaling | Other |
1 | [23] | 1 | Asn10Lys | 1 | ECD | ↓ | ↓ | |
2 | [33] | 1 | Asn10Lys+Gln11Lys | 1 | ECD | ↓ | ↓ | |
3 | [21, 29] | 1 | Thr32lle | 1 | ECD | ↓ | ↓ | |
4 | [20, 25] | 1 | Glu90Lys | 2 | TMD2 | ↓ | ↓ | |
5 | [1, 17, 21-24] | 1 | Gln106Arg | 13 | ECL1 | ↓ | ↓ | |
6 | [14, 26] | 1 | Ala129Asp | 2 | TMD3 | ↓ | ↓ | |
7 | [23, 31] | 1 | Arg139His | 4 | TMD3/ICL2 | Absent | ↓ | ↓ receptor # |
8 | [34] | 1 | Arg139Cys | 2 | TMD3/ICL2 | Normal | ↓ | |
9 | [16] | 1 | Ser168Arg | 2 | TMD4 | ↓ | ↓ | |
10 | [32] | 1 | Ala171Thr | 1 | TMD4 | Absent | ↓ | |
11 | [21, 29] | 2 | Cys200Tyr | 1 | ECL2 | ↓ | ↓ | |
12 | [15] | 2 | Gln106Arg/Ser217Arg | 1 | ECL1/TMD5 | ↓ | ↓ | |
13 | [1, 2, 14, 17, 21, 26, 35] | 3 | Arg262Gln | 8 | ICL3 | Normal | ↓ | |
14 | [21, 29] | 3 | Leu266Arg | 2 | ICL3 | ↓ | ↓ | |
15 | [21, 29] | 3 | Cys279Tyr | 2 | TMD6 | ↓ | ↓ | |
16 | [2] | 3 | Tyr284Cys | 1 | TMD7 | Normal | ↓ | |
17 | [33] | 3 | Pro320Leu | 1 | TMD7 | Absent | ↓ | |
Other Mutations | ||||||||
18 | [27] | IVS1 | IVS1-1G→A | 2 | Exon2 skip | ND | ND | |
19 | [18] | 3 | Leu314X | 1 | TMD7 | ↓ | ↓ | |
Other Reported Alleles Not Studied In Vitro | ||||||||
20 | [37] | 1 | Leu83Val | 1 | ND | ND | ||
21 | [37] | 1 | Pro96Ser | 1 | ND | ND | ||
22 | [36] | 1 | Thr104Ile | 1 | ND | ND | ||
23 | [36] | 1 | Tyr108Cys | 1 | ND | ND | ||
24 | [38] | 1 | Pro146Ser | 2 | ND | ND |
Missense mutations are ordered by codon number. Five additional alleles (#20-24) have also been reported, but not studied in vitro. Only newly identified alleles were included from Cerrato et al[37] since it was not possible to determine which patients with known causative alleles had been reported previously.
ND= not done;ECD = extracellular domain; ECL = extracellular loop, TMD = transmembrane domain; ICL = intracellular loop.